Skip to main content
. 2020 Apr 24;10:7004. doi: 10.1038/s41598-020-64018-z

Figure 6.

Figure 6

ADR-resistant (R) MDA-MB-231 cells are also resistant to SM-164, while SM-164-R MDA-MB-231 cells are sensitive to ADR. (A) Growth curve of the parental and ADR-R MDA-MB-231 cells, starting at 1 × 104 cells/well, in a well of 6-well-plates treated with 30 ng/ml ADR or vehicle, and passaged to 60- and 100-mm dishes, respectively, when untreated cells grew to sub-confluence. 3 wells/group, **p < 0.01, one-way ANOVA +/Dunnett test. (B) Parental and ADR-R MDA-MB-231cells were treated with the indicated doses of SM-164 plus 1 ng/ml of TNFα overnight. Annexin V+PI+/− apoptotic cells were analyzed by flow cytometry. (C) 0.5 × 104 parental and SM-R MDA-MB-231 cells in 60 mm dishes were cultured overnight followed by treatment with 1 ng/ml TNFα plus the indicated doses of SM-164 for 3 days, and surviving cells were counted. (D) The parental and SM-164-R cells (0.5 × 104 cells in 60 mm dishes) were treated with the indicated doses of ADR for 6 days and cell numbers were counted after digestion with 0.2% trypsin. **p < 0.01 vs. the respective parental cells, one-way ANOVA +/Dunnett test. The experiments were repeated 3 times with similar results.